Physician

Sousan Lehimagar Zadeh, DO

According to 2025 Medicare claims, Sousan Zadeh, DO (NPI: 1194920710) practices nephrology in the Hammond, LA market, with the plurality of this provider's patient population coming from Tangipahoa, LA. This provider's primary affiliated billing organization is INTERNAL MEDICINE CLINIC OF TANGIPAHOA, LLC (NPI: 1588678494; TIN: 030417452) and primary practice location at 70403-1434. Zadeh is affiliated with the Imperium Clinical Partners II, LLC (ACO ID: A5523), participating under the MSSP model.

Zadeh's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 375 traditional Medicare patients, billed 2,513 HCPCS/CPT codes, and received $157,258 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 1,762 prescription claims across 278 beneficiaries totaling $134,371 in drug costs, led by Kerendia (Finerenone). DME data shows 65 claims. Open Payments data shows 4 records totaling $169. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a higher plateau to a lower plateau, from $382,626 to $157,258. Similarly, Part D prescription costs have fallen sharply in recent years, from $269,454 to $134,371. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$210K$419K2015 Medicare payment: $382,626 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $419,060 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $408,187 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $314,794 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $323,905 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $273,403 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $239,595 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $216,080 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $195,786 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $157,258 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20155957,744$382,626
20166279,090$419,060
20176368,560$408,187
20186086,656$314,794
20195807,409$323,905
20205246,044$273,403
20214854,796$239,595
20224674,659$216,080
20234363,770$195,786
20243752,513$157,258

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$186K$373K2015 Drug cost: $269,454 (USD; Tot_Drug_Cst)2016 Drug cost: $372,621 (USD; Tot_Drug_Cst)2017 Drug cost: $343,266 (USD; Tot_Drug_Cst)2018 Drug cost: $315,066 (USD; Tot_Drug_Cst)2019 Drug cost: $209,855 (USD; Tot_Drug_Cst)2020 Drug cost: $203,295 (USD; Tot_Drug_Cst)2021 Drug cost: $165,757 (USD; Tot_Drug_Cst)2022 Drug cost: $152,338 (USD; Tot_Drug_Cst)2023 Drug cost: $108,384 (USD; Tot_Drug_Cst)2024 Drug cost: $134,371 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20153222,697$269,454
20163152,735$372,621
20173022,388$343,266
20182772,262$315,066
20193022,026$209,855
20202701,783$203,295
20212591,673$165,757
20222951,679$152,338
20233021,817$108,384
20242781,762$134,371

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$690$1.4K2024 Medicare payment: $1,381 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023N/RN/RN/R
2024N/R65$1,381

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99223Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes119180$136
99233Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes90405$93
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more184288$87
99232Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes113432$61
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's190247$13

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
KerendiaFinerenone16930$18,669
VeltassaPatiromer Calcium Sorbitex17510$17,324
AuryxiaFerric Citrate11418$15,650
FarxigaDapagliflozin Propanediol19570$10,917
LokelmaSodium Zirconium Cyclosilicate13480$10,330

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
J7507Tacrolimus, immediate release, oral, 1 mgNN/R24$842
Q0511Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day periodNN/R16$282
Q0512Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day periodNN/R13$163
J7517Mycophenolate mofetil, oral, 250 mgNN/R12$93

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.4$169Alon Medical Technology
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Sousan Lehimagar Zadeh, DO?

Tedicare shows public-source Medicare data for Sousan Lehimagar Zadeh, DO (NPI 1194920710), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Sousan Lehimagar Zadeh, DO have ACO affiliation data?

Sousan Lehimagar Zadeh, DO is shown with ACO affiliation data for Imperium Clinical Partners II, LLC (MSSP, ACO ID A5523).

What billing organization is linked to Sousan Lehimagar Zadeh, DO?

Sousan Lehimagar Zadeh, DO is linked to INTERNAL MEDICINE CLINIC OF TANGIPAHOA, LLC (billing NPI 1588678494) in the available physician profile data.

Does Sousan Lehimagar Zadeh, DO have Open Payments data?

Sousan Lehimagar Zadeh, DO has 4 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.